Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tango Therapeutics (TNGX) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Tango Therapeutics (TNGX) over the last 5 years, with Q2 2025 value amounting to $110.5 million.

  • Tango Therapeutics' Shares Outstanding (Diluted Average) rose 170.02% to $110.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $110.5 million, marking a year-over-year increase of 170.02%. This contributed to the annual value of $109.2 million for FY2024, which is 1549.53% up from last year.
  • Latest data reveals that Tango Therapeutics reported Shares Outstanding (Diluted Average) of $110.5 million as of Q2 2025, which was up 170.02% from $110.3 million recorded in Q1 2025.
  • Over the past 5 years, Tango Therapeutics' Shares Outstanding (Diluted Average) peaked at $110.5 million during Q2 2025, and registered a low of $48.5 million during Q2 2021.
  • In the last 5 years, Tango Therapeutics' Shares Outstanding (Diluted Average) had a median value of $88.4 million in 2023 and averaged $91.5 million.
  • Per our database at Business Quant, Tango Therapeutics' Shares Outstanding (Diluted Average) skyrocketed by 8102.15% in 2022 and then skyrocketed by 58.61% in 2023.
  • Over the past 5 years, Tango Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $62.1 million in 2021, then skyrocketed by 41.4% to $87.8 million in 2022, then increased by 7.69% to $94.6 million in 2023, then increased by 15.5% to $109.2 million in 2024, then increased by 1.2% to $110.5 million in 2025.
  • Its last three reported values are $110.5 million in Q2 2025, $110.3 million for Q1 2025, and $109.2 million during Q4 2024.